Switching from originator infliximab to the biosimilar...

Therapeutic Advances in Gastroenterology 2018 / 01 Vol. 11

Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease

Bergqvist, Viktoria, Kadivar, Mohammad, Molin, Daniel, Angelison, Leif, Hammarlund, Per, Olin, Marie, Torp, Jörgen, Grip, Olof, Nilson, Stefan, Hertervig, Erik, Lillienau, Jan, Marsal, Jan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Language:
english
Journal:
Therapeutic Advances in Gastroenterology
DOI:
10.1177/1756284818801244
Date:
January, 2018
File:
PDF, 790 KB
english, 2018
Conversion to is in progress
Conversion to is failed